461 related articles for article (PubMed ID: 34346049)
1. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
Rzepiński Ł; Zawadka-Kunikowska M
Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 infection in myasthenia gravis: Clinical course and outcomes.
Thomas EV; Bou G; Barton S; Hutto S; Garcia-Santibanez R
Muscle Nerve; 2023 Aug; 68(2):171-175. PubMed ID: 37326164
[TBL] [Abstract][Full Text] [Related]
3. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
[TBL] [Abstract][Full Text] [Related]
4. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
[TBL] [Abstract][Full Text] [Related]
5. Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19.
Gungor Tuncer O; Deymeer F
Muscle Nerve; 2022 Apr; 65(4):447-452. PubMed ID: 35040147
[TBL] [Abstract][Full Text] [Related]
6. Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.
Czarnowska A; Brola W; Zajkowska O; Rusek S; Adamczyk-Sowa M; Kubicka-Bączyk K; Kalinowska-Łyszczarz A; Kania K; Słowik A; Wnuk M; Marona M; Podlecka-Piętowska A; Nojszewska M; Zakrzewska-Pniewska B; Jasińska E; Gołuch K; Lech B; Noga M; Perenc A; Popiel M; Lasek-Bal A; Puz P; Maciejowska K; Kucharska-Lipowska M; Lipowski M; Kapica-Topczewska K; Chorąży M; Tarasiuk J; Kochanowicz J; Kulikowska J; Wawrzyniak S; Niezgodzińska-Maciejek A; Pokryszko-Dragan A; Gruszka E; Budrewicz S; Białek M; Kurkowska-Jastrzębska I; Kurowska K; Stępień A; Włodek A; Ptasznik V; Pawełczyk M; Sobolewski P; Lejmel H; Strzalińska K; Maciejowski M; Tutaj A; Zwiernik J; Litwin A; Lewańczyk B; Paprocka I; Zwiernik B; Pawlos A; Borysowicz A; Narożnik A; Michałowska A; Nosek K; Fudala M; Milewska-Jędrzejczak M; Kułakowska A; Bartosik-Psujek H
Neurol Neurochir Pol; 2021; 55(2):212-222. PubMed ID: 33856686
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 Infection and Its Association With Previous Vaccination in Patients With Myasthenia Gravis in Korea: A Multicenter Retrospective Study.
Han HJ; Kim SW; Kim H; So J; Lee EJ; Lim YM; Lee JH; Lee MA; Kim BJ; Baek SH; Lee HS; Sohn E; Kim S; Park JS; Kang M; Park HJ; Yoon BA; Kim JK; Seok HY; Kim S; Min JH; Chung YH; Cho JH; Kim JE; Oh SI; Shin HY
J Korean Med Sci; 2024 May; 39(18):e150. PubMed ID: 38742290
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.
Businaro P; Vaghi G; Marchioni E; Diamanti L; Arceri S; Bini P; Colombo E; Cosentino G; Alfonsi E; Costa A; Ravaglia S; Mallucci G; Ballante E; Franciotta D; Gastaldi M
Muscle Nerve; 2021 Aug; 64(2):206-211. PubMed ID: 34031902
[TBL] [Abstract][Full Text] [Related]
9. Impact of COVID-19 infection among myasthenia gravis patients- a Cerner Real-World Data
Digala LP; Prasanna S; Rao P; Qureshi AI; Govindarajan R
BMC Neurol; 2022 Jan; 22(1):38. PubMed ID: 35086486
[TBL] [Abstract][Full Text] [Related]
10. Myasthenia gravis and COVID-19: A case series and comparison with literature.
Saied Z; Rachdi A; Thamlaoui S; Nabli F; Jeridi C; Baffoun N; Kaddour C; Belal S; Ben Sassi S
Acta Neurol Scand; 2021 Sep; 144(3):334-340. PubMed ID: 33914898
[TBL] [Abstract][Full Text] [Related]
11. Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19.
Scopelliti G; Osio M; Arquati M; Pantoni L
Neurol Sci; 2020 Dec; 41(12):3419-3421. PubMed ID: 33068195
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
Ramaswamy SB; Govindarajan R
J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
[TBL] [Abstract][Full Text] [Related]
13. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubíková M; Týblová M; Tesař A; Horáková M; Vlažná D; Ryšánková I; Nováková I; Dolečková K; Dušek P; Piťha J; Voháňka S; Bednařík J
Eur J Neurol; 2021 Oct; 28(10):3418-3425. PubMed ID: 34080271
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder and Myasthenia Gravis during the COVID-19 Pandemic].
Nakamura M; Nakashima I
Brain Nerve; 2020 Oct; 72(10):1079-1083. PubMed ID: 33051396
[TBL] [Abstract][Full Text] [Related]
15. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review.
Rodrigues CL; de Freitas HC; Lima PRO; de Oliveira Junior PH; Fernandes JMA; D'Almeida JAC; Nóbrega PR
Neurol Sci; 2022 Apr; 43(4):2271-2276. PubMed ID: 35039987
[TBL] [Abstract][Full Text] [Related]
16. Experience of the Polish Medical Air Rescue Service During the First Year of the COVID-19 Pandemic and Measures Taken to Protect Patients, Medical Staff, and Air Crew from SARS-CoV-2 Infection.
Rzońca P; Tomaka P; Rzońca E; Gałązkowski R
Med Sci Monit; 2022 Feb; 28():e935474. PubMed ID: 35221329
[TBL] [Abstract][Full Text] [Related]
17. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
Stascheit F; Grittner U; Hoffmann S; Mergenthaler P; Schroeter M; Ruck T; Pawlitzki M; Blaes F; Kaiser J; Schara U; Della-Marina A; Thieme A; Hagenacker T; Jacobi C; Berger B; Urban PP; Knop KC; Schalke B; Lee DH; Kalischewski P; Wiendl H; Meisel A
J Neurol; 2023 Jan; 270(1):1-12. PubMed ID: 36166068
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis and telemedicine: a lesson from COVID-19 pandemic.
Ricciardi D; Casagrande S; Iodice F; Orlando B; Trojsi F; Cirillo G; Clerico M; Bozzali M; Leocani L; Abbadessa G; Miele G; Tedeschi G; Bonavita S; Lavorgna L;
Neurol Sci; 2021 Dec; 42(12):4889-4892. PubMed ID: 34436726
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Impact of COVID-19 on Vaccinated and Unvaccinated Patients Affected by Myasthenia Gravis.
Scarsi E; Massucco S; Ferraro PM; Cella A; Grisanti SG; Assini A; Beronio A; Della Cava F; Gemelli C; Bandini F; Serrati C; Del Sette M; Schenone A; Benedetti L; Prada V; Grandis M
Life (Basel); 2023 Apr; 13(4):. PubMed ID: 37109594
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.
Shah SMI; Yasmin F; Memon RS; Jatoi NN; Savul IS; Kazmi S; Monawwer SA; Zafar MDB; Asghar MS; Tahir MJ; Lee KY
Brain Behav; 2022 Dec; 12(12):e2789. PubMed ID: 36306401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]